Hein Sascha, Benz Nuka Ivalu, Eisert Jonathan, Herrlein Marie-Luise, Oberle Doris, Dreher Michael, Stingl Julia C, Hildt Christoph, Hildt Eberhard
Department of Virology, Paul-Ehrlich-Institut, Paul-Ehrlich Street 51-59, D-63225 Langen, Germany.
Division of Pharmacovigilance, Paul-Ehrlich-Institut, Paul-Ehrlich Street 51-59, D-63325 Langen, Germany.
Vaccines (Basel). 2021 Dec 1;9(12):1419. doi: 10.3390/vaccines9121419.
Many of the approved SARS-CoV-2 vaccines are based on a stabilized variant of the spike protein. This raises the question of whether the immune response against the stabilized spike is identical to the immune response that is elicited by the native spike in the case of a SARS-CoV-2 infection. Using a peptide array-based approach, we analysed the binding of antibodies from Comirnaty-elicited, convalescent, and control sera to the peptides covering the spike protein. A total of 37 linear epitopes were identified. A total of 26 of these epitopes were almost exclusively recognized by the convalescent sera. Mapping these epitopes to the spike structures revealed that most of these 26 epitopes are masked in the pre-fusion structure. In particular, in the conserved central helix, three epitopes that are only exposed in the post-fusion conformation were identified. This indicates a higher spike-specific antibody diversity in convalescent sera. These differences could be relevant for the breadth of spike-specific immune response.
许多已获批的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗都是基于刺突蛋白的稳定变体。这就引发了一个问题,即针对稳定化刺突的免疫反应是否与SARS-CoV-2感染情况下天然刺突引发的免疫反应相同。我们采用基于肽阵列的方法,分析了来自接种Comirnaty疫苗者的血清、康复者血清和对照血清中的抗体与覆盖刺突蛋白的肽段的结合情况。共鉴定出37个线性表位。其中共有26个表位几乎仅被康复者血清识别。将这些表位映射到刺突结构上发现,这26个表位中的大多数在融合前结构中是被掩盖的。特别是,在保守的中央螺旋中,鉴定出了三个仅在融合后构象中暴露的表位。这表明康复者血清中刺突特异性抗体的多样性更高。这些差异可能与刺突特异性免疫反应的广度有关。